⭐ The authority on professional skin care for over 50 years - Subscribe today! Subscribe Now

Revance Therapeutics, Inc recently announced that Mark A. Prygocki has been appointed to its board of directors

Please login to like posts.

📖 1 min read

Revance Therapeutics, Inc., a specialty biopharmaceutical company that develops botulinum toxin products for use in aesthetic and therapeutic indications, recently announced that Mark A. Prygocki has been appointed to its board of directors and as the chair of its audit committee.

0 Comments

No comments yet. Be the first to comment!

Wait! Before You Go

Check out these exclusive offers you might be interested in